Decheng Capital China Life Sciences USD Fund III is a Venture Capital Fund in Cayman Islands with $721.52 mm assets under management, with a minimum investment of $5.00 mm. It has 34 beneficial owners. Data from SEC filing.
Company profile
Employees
Incorporated
Location
Fiscal year end
Industry
SEC CIK
AUM ?
$721.52 mm
Address
Decheng Capital China Life Sciences USD Fund III
UGLAND HOUSE, PO BOX 309
GRAND CAYMAN
E9 KY1-1104
UGLAND HOUSE, PO BOX 309
GRAND CAYMAN
E9 KY1-1104
Phone
345-949-8066
Ownership
Fund structure | AUM | Fund type |
---|---|---|
Decheng Capital LLC | $2.21 bn | |
Decheng Capital China Life Sciences Usd Fund I, L.P. | $202.94 mm | Venture Capital Fund |
Decheng Capital China Life Sciences Usd Fund II, L.P. | $510.13 mm | Venture Capital Fund |
Decheng Capital China Life Sciences Usd Fund III, L.P. | $721.52 mm | Venture Capital Fund |
Decheng Capital Global Healthcare Fund (Master), LP | $95.72 mm | Hedge Fund |
Decheng Capital Global Life Sciences Fund IV, L.P. | $252.65 mm | Venture Capital Fund |
Latest filings (excl ownership)
Latest ownership filings
4
ALPINE IMMUNE SCIENCES, INC.
22 Jan 24
SC 13D/A
ALPINE IMMUNE SCIENCES, INC.
14 Nov 23
4
ALPINE IMMUNE SCIENCES, INC.
27 Sep 22
SC 13D/A
ALPINE IMMUNE SCIENCES, INC.
27 Sep 22
4
Cue Health Inc.
30 Sep 21
3
Xiangmin Cui
23 Sep 21
4
ALPINE IMMUNE SCIENCES, INC.
21 Sep 21
SC 13D/A
ALPINE IMMUNE SCIENCES, INC.
21 Sep 21
SC 13D/A
BeyondSpring Inc.
8 Dec 20
SC 13D/A
ALPINE IMMUNE SCIENCES, INC.
3 Aug 20